SCHEMBL5708278

SCHEMBL5708278

O=C(Cl)C1C=CC=CC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL797535 0.79
SCHEMBL26134640 0.77
SCHEMBL27553208 0.77
SCHEMBL28667138 0.76
SCHEMBL27901874 0.76
SCHEMBL28166935 0.75
Fluoride SCHEMBL27841847 0.74
SCHEMBL9868040 0.74
SCHEMBL29077415 0.74
SCHEMBL30476273 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3814485-A1 NATURAL KILLER CELLS Imperial College Innovations Limited (GB) 2021-05-05 EP disclosed
WO-2017079120-A1 ROR GAMMA AGONISTS AS ENHANCERS OF PROTECTIVE IMMUNITY THE SCRIPPS RESEARCH INSTITUTE (US) 2017-05-11 WO disclosed
WO-2016146689-A1 ORGANOZINC REAGENTS AND PROCESSES FOR PREPARING AND USING THE SAME LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2016-09-22 WO disclosed
EP-1711617-A1 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTICS COMPOUNDS GILEAD SCIENCES, INC. (US) 2006-10-18 EP disclosed
WO-2005064008-A1 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2005-07-14 WO disclosed